Lexicon Pharma (LXRX) Tops Q3 EPS by 7c, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 1.50 +0.04 (2.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.46 | 52 Week High | $19.62 | |||
| Open | $1.50 | 52 Week Low | $7.65 | |||
| Day High | $1.54 | P/E | N/A | |||
| Day Low | $1.46 | EPS | $-0.22 | |||
| Volume | 678,133 | |||||
